What We're Reading: Page 184
Industry reads hand-picked by our editors
Jun 24, 2020
-
Scientific American
Inside the Coronavirus
-
Chemical & Engineering News
One molecule’s journey from discovery to market
-
STAT
Human challenge trials with live coronavirus aren’t the answer to a Covid-19 vaccine
Jun 23, 2020
Jun 22, 2020
-
The Atlantic
Why People Are Drinking Silver for COVID-19
-
The Wall Street Journal
Rules for Clinical Trials in a Pandemic
-
FierceBiotech
Roche, BioNTech post 'low' response rate in cancer vaccine trial
Jun 19, 2020
-
The New York Times
Can a Billionaire’s Son Spend His Way to a House Seat in New York?
-
Bloomberg
Older Adults Struggle to Get Pfizer's $225,000-a-Year Heart Drug
-
Reuters
U.S. hospitals in hard hit regions step up use of steroids on sickest COVID-19 patients
-
Bloomberg Law
Rush for generic go-ahead on novel drugs roils pharma industry
Jun 18, 2020
-
The Washington Post
Before the pandemic, top contractor received billions from government to help prepare the nation for biowarfare
-
STAT
How likely are kids to get Covid-19? Scientists see a ‘huge puzzle’ without easy answers
-
South China Morning Post
Can China win Covid-19 vaccine race with old school technology?
Jun 17, 2020
Jun 16, 2020
-
The New York Times
Most Coronavirus Tests Cost About $100. Why Did One Cost $2,315?
-
Science Translational Medicine
What Might Go Wrong
-
Xconomy
Jazz Pharma Gets Quick FDA OK for New Small Cell Lung Cancer Drug
-
STAT
What’s at stake for industry in the pharmaceutical Space Race for a Covid-19 vaccine
Previous
